Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology |
| December 07, 2021 | December 2021 Bond Updates |
|
SALT LAKE CITY, Dec. 7, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development and beyond through disruptive innovation, today announced a transformational... |
| View more at: https://www.prnewswire.com:443/news-releases/recursion-announces-transformational-collaboration-with-roche-and-genentech-in-neuroscience-and-oncology-advancing-novel-medicines-to-patients-using-machine-learning-and-high-content-screening-methods-at-scale- |
| Related News |